Seelaus Asset Management LLC Northwest Biotherapeutics Inc Transaction History

Seelaus Asset Management LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 08, 2019	SELL	$0.2 - $0.28 $10,000 - $14,000	-50,000 Closed	0 $0
Q1 2018 May 07, 2018	BUY	$0.25 - $0.37 $12,500 - $18,500	50,000 New	50,000 $13,000

687K

Ticker NWBO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,037,230,016
Market Cap $280M
Description
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...

Get notified when there are updates to the investment portfolio of Seelaus Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Seelaus Asset Management LLC with notifications on news.